Reduced Circulating miR-15b Is Correlated with Phosphate Metabolism in Patients with End-Stage Renal Disease on Maintenance Hemodialysis

REFERENCES

• Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 2009; 4:1255–1266.
   PubMed Web of Science ®Google Scholar
• Sequeira Lopez ML, Gomez RA. Novel mechanisms for the control of renin synthesis and release. Curr Hypertens Rep. 2010;12:26–32.
   PubMed Web of Science ®Google Scholar
• Li JY, Yong TY, Michael MZ, Gleadle JM. Review: The role of microRNAs in kidney disease. Nephrology (Carlton). 2010;15:599–608.
   PubMed Web of Science ®Google Scholar
• Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int. 2009;29:749–754.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, . Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108:5003–5008.
   PubMed Web of Science ®Google Scholar
• Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010;5:e13735.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677–684.
   PubMed Web of Science ®Google Scholar
• Tijsen AJ, Creemers EE, Moerland PD, MiR423-5p as a circulating biomarker for heart failure. Circ Res. 2010;106: 1035–1039.
   PubMed Web of Science ®Google Scholar
• Lorenzo Sellares V, Torregrosa V. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Nefrologia. 2008;28(Suppl 3):67–78.
   Google Scholar
• Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC. miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 2011;179:1594–1600.
   PubMed Web of Science ®Google Scholar
• Boucher JM, Peterson SM, Urs S, Zhang C, Liaw L. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J Biol Chem. 2011;286:28312–28321.
   PubMed Web of Science ®Google Scholar
• Finnerty JR, Wang WX, Hebert SS, Wilfred BR, Mao G, Nelson PT. The miR-15/107 group of microRNA genes: Evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol. 2010;402:491–509.
   PubMed Web of Science ®Google Scholar
• Gao J, Yang T, Han J, MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem. 2011;112: 1844–1856.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Neal CS, Michael MZ, Pimlott LK, Yong TY, Li JY, Gleadle JM. Circulating microRNA expression is reduced in chronic kidney disease. Nephrol Dial Transplant. 2011;26:3794–3802.
   PubMed Web of Science ®Google Scholar
• Floege J, Kim J, Ireland E, Serum iPTH, calcium and phosphate, and the risk of mortality in a European hemodialysis population. Nephrol Dial Transplant. 2011;26:1948–1955.
   PubMed Web of Science ®Google Scholar
• Kendrick J, Chonchol M. The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis. 2011;58:826–834.
   PubMed Web of Science ®Google Scholar
• Ossareh S. Vascular calcification in chronic kidney disease: Mechanisms and clinical implications. Iran J Kidney Dis. 2011;5:285–299.
   PubMed Web of Science ®Google Scholar
• Arcidiacono T, Paloschi V, Rainone F, Renal osteodystrophy and vascular calcification. J Endocrinol Invest. 2009; 32:21–26.
   Google Scholar
• Gattineni J, Baum M. Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): Implications for disorders of phosphate metabolism. Pediatr Nephrol. 2010; 25:591–601.
   Google Scholar
• Gupta D, Brietzke S, Hayden MR, Kurukulasuriya LR, Sowers JR. Phosphate metabolism in cardiorenal metabolic disease. Cardiorenal Med. 2011;1:261–270.
   Google Scholar
• Nakai K, Komaba H, Fukagawa M. New insights into the role of fibroblast growth factor 23 in chronic kidney disease. J Nephrol. 2010;23:619–625.
   PubMed Web of Science ®Google Scholar
• Tesse A, Martinez MC, Meziani F, Origin and biological significance of shed-membrane microparticles. Endocr Metab Immune Disord Drug Targets. 2006;6:287–294.
   Google Scholar
• Zampetaki A, Kiechl S, Drozdov I, Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107:810–817.
   PubMed Web of Science ®Google Scholar
• Valdivielso JM. [Vascular calcification: Types and mechanisms]. Nefrologia. 2011;31:142–147.
   PubMed Web of Science ®Google Scholar
• Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97: 2307–2315.
   PubMed Web of Science ®Google Scholar
• Yue J, Tigyi G. Conservation of miR-15a/16-1 and miR-15b/16-2 clusters. Mamm Genome. 2010;21:88–94.
   PubMed Web of Science ®Google Scholar
• Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol. 2009;50:766–778.
   PubMed Web of Science ®Google Scholar
• Prokopi M, Pula G, Mayr U, Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009;114:723–732.
   PubMedGoogle Scholar